What is the Sibionics GS1 CGM?

Image courtesy of Sibionics.

Find out about the Sibionics GS1 CGM, newly available in limited European countries. We outline the key features and give you a comparison with similar medtech so that you can evaluate if this is suitable for your needs.

Key features

• Calibration-free: Eliminates the need for manual finger prick calibrations.

• Wear-time: Each sensor is designed for a 14-day wear period.

• Accuracy: Reports indicate a Mean Absolute Relative Difference (MARD) of 8.83%, suggesting reliable glucose readings.

• User-Friendly App: The accompanying mobile application provides real-time glucose data, trend analysis, and customisable alerts.

• Water resistance: The device is rated IP28.

Customer insights

Pros

• First-time users like its simple interface and comfortable wear.

• Users on forums groups say it’s "refreshing to try a new CGM that’s more affordable."

  
  

Cons

• Some users report that the app lacks features like real-time sharing with healthcare teams.

• 
  

CGM Comparison

Feature	Sibionics GS1	FreeStyle Libre 2 Plus	Dexcom G7
Sensor shape & size		Circular, 35mm x 5mm	Irregular shape, 60% smaller than G6
Sensor wear duration	14 days	15 days	10 days
Warm-up time	1 hour	1 hour	30 minutes
Application		Two-part application	One-piece applicator
Optional calibration		No	Yes
Data transmission
Integrations	Sibionics app	LibreLink & LibreView apps	Dexcom App + Clarity, Apple Watch integration
Alerts	Yes, customisable	Yes, optional	Yes with predictive high & low alarms
Water resistance	IP28	IP67	IP68
Approved wear sites (UK)
MARD	8.83%	8.2%	9.2%
Reader availability
Direct to Smartwatch	No	No	Yes
Approved age (UK)
Grace period	No	No	Yes, 12 hours

For complete details on each option please refer to manuafacture's website and documentation.

Manufacturer overview

Company Name: Shenzhen Sibionics Technology Co., Ltd.

Website:

Founded: 2015

Headquarters: Shenzhen, China

Global Presence: Over 1,000,000 users worldwide

Workforce: Over 700 employees, with more than 40% dedicated to research and development

Annual Production Capacity: 6,000,000 CGM units

Global Reach and Achievements

SIBIONICS has rapidly grown to become the world's third-largest CGM brand. The company's GS1 CGM system has been integrated into inpatient treatments across 1,600 hospitals, benefiting over 600,000 users globally. In 2023, the GS1 CGM received the CE Mark, allowing its distribution and utilisation throughout the European market.

Research and Development

The company places a strong emphasis on research and development, with over 40% of its workforce engaged in R&D efforts. This focus has led to the development of innovative products like the KS1 Continuous Ketone Monitoring System (CKM), a consumer-grade biowearable that helps patients achieve and maintain ketosis. The KS1 CKM features up to 14 days of uninterrupted usage, real-time tracking via an app, and personalized ketogenic diet guidance.

Notes

• Always consult a healthcare professional to determine the best CGM for your personal needs.

• Wear site approval may vary by country and regulatory status. Always follow the manufacturer's instructions.